Adherence to medication under mandatory and voluntary mail benefit designs

American Journal of Managed Care

Volumn 17, Issue 7, 2011, Pages

  Liberman, Joshua N ^a   Hutchins, David S ^b   Shrank, Will H ^c,d   Slezak, Julie ^e   Brennan, Troyen A ^b  

^a GEISINGER HEALTH SYSTEM   (United States)

^b CVS Caremark   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Silverlink Communications   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; SULFONYLUREA;

ADULT; AGED; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDATORY REPORTING; MODEL; PATIENT COMPLIANCE; PHARMACY; POSTAL MAIL; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; VOLUNTARY REPORTING;

AGE FACTORS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; METFORMIN; MIDDLE AGED; PHARMACEUTICAL SERVICES; PLATELET AGGREGATION INHIBITORS; POSTAL SERVICE; PRESCRIPTION DRUGS; PRESCRIPTION FEES; SEX FACTORS; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 79960763117     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Shrank WH, Porter ME, Jain SH, Choudhry NK. A blueprint for pharmacy benefit managers to increase value. Am J Manag Care. 2009;15(2):87-93.
2. The Kaiser Family Foundation and Health Research and Educational Trust. Employer health benefits 2010 annual survey. Section 9. Prescription drug benefits. Exhibit 9.1:161-171. http://ehbs.kff.org/. Accessed March 31, 2011.
3. Pharmacy Benefit Management Institute. Prescription Drug Benefit Cost and Plan Design Report. 2010-2011 ed. Page 11. http://www.benefitdesignreport. com/. Accessed December 6, 2010.
4. US General Accounting Office. Federal Employee's Health Benefits. Effects of Using Pharmacy Benefit Managers on Health Plans, Enrollees, and Pharmacies. January 2003. GAO publication 03-196. www.gao.gov/new.items/d03196.pdf. Accessed March 31, 2011.
5. IMS Health. Channel Distribution by U.S. Dispensed Prescriptions. http://www.imshealth.com/portal/site/imshealth/menuitem. a46c6d4df3db4b3d88f611019418c22a/?vgnextoid= ed2e5a6b5895f210VgnVCM100000ed152ca2RCRD&vgnextfmt=default. Accessed March 31, 2011.
6. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350. (Pubitemid 38656301)
7. Duru OK, Schmittdiel JA, Dyer WT, et al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;16(1):33-40.
8. Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ. 2010;13(2):203-211.
9. Wal-Mart. Wal-Mart launches phase three of $4 prescription program: company adds 90-day prescriptions for $10, more women's health offerings, and $4 over-the-counter medicines in its latest "health care reform" move. http://walmartstores.com/pressroom/news/8248.aspx. Published May 5, 2008. Accessed March 31, 2011.
10. Walgreens. Walgreens to promote 90-day prescriptions at community pharmacies in Minneapolis: 90-day supplies at retail locations brings significant benefits to patients and dramatically improves convenience and adherence to medication. http://www.businesswire.com/news/home/20100803006228/ en/Walgreens-Promote-90-Day- Prescriptions-Community-Pharmacies-Minneapolis. Published August 3, 2010. Accessed March 31, 2011.
11. Desselle SP. Determinants of satisfaction with prescription drug plans. Am J Health Syst Pharm. 2001;58(12):1110-1119. (Pubitemid 32552895)
12. Johnson JA, Coons SJ, Hays RD, Sabers D, Jones P, Langley PC. A comparison of satisfaction with mail versus traditional pharmacy services. J Manag Care Pharm. 1997;3:327-337.
13. Liberman JN, Wang Y, Hutchins DS, Slezak J, Shrank WH. Revealed preference for community and mail service pharmacy. J Am Pharm Assoc. 2011;51(1):50-57.
14. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730-740. (Pubitemid 41608213)
15. National Community Pharmacists Association. Fact sheet: PBMs and mail order. http://www.ncpanet.org/pdf/pbm-factsheet.pdf. Published January 2007. Accessed July 6, 2011.
16. Roebuck MC, Liberman JN. Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data. Health Serv Res. 2009;44(3):988-1009.
17. Linton A, Garber M, Fagan NK, Peterson M. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older. J Manage Care Pharm. 2007;13(8):677-686. (Pubitemid 350065236)
18. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
19. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69. (Pubitemid 47026771)
20. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332-337. (Pubitemid 43244321)